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Surgical Compared with Nonoperative Treatment
for Lumbar Degenerative Spondylolisthesis
Four-Year Results in the Spine Patient Outcomes Research Trial
(SPORT) Randomized and Observational Cohorts
By James N. Weinstein, DO, MS, Jon D. Lurie, MD, MS, Tor D. Tosteson, ScD, Wenyan Zhao, MS, Emily A. Blood, MS,
Anna N.A. Tosteson, ScD, Nancy Birkmeyer, PhD, Harry Herkowitz, MD, Michael Longley, MD,
Lawrence Lenke, MD, Sanford Emery, MD, and Serena S. Hu, MD
Investigation performed at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, William Beaumont Hospital, Royal Oak, Michigan,
Nebraska Foundation for Spinal Research, Omaha, Nebraska, Washington University, St. Louis, Missouri, Case Western Reserve/University Hospitals of
Cleveland, Cleveland, Ohio, University of California, San Francisco, California, Emory University, Atlanta, Georgia, Hospital for Joint Diseases, New York,
NY, The Hospital for Special Surgery, New York, NY, Rothman Institute at Thomas Jefferson University, Philadelphia, Pennsylvania, Kaiser-Permanente,
Oakland, California, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois, and Maine Spine and Rehabilitation, Scarborough, Maine

Background: The management of degenerative spondylolisthesis associated with spinal stenosis remains controversial. Surgery
is widely used and has recently been shown to be more effective than nonoperative treatment when the results were followed over
two years. Questions remain regarding the long-term effects of surgical treatment compared with those of nonoperative treatment.
Methods: Surgical candidates from thirteen centers with symptoms of at least twelve weeks’ duration as well as
confirmatory imaging showing degenerative spondylolisthesis with spinal stenosis were offered enrollment in a randomized
cohort or observational cohort. Treatment consisted of standard decompressive laminectomy (with or without fusion) or
usual nonoperative care. Primary outcome measures were the Short Form-36 (SF-36) bodily pain and physical function
scores and the modified Oswestry Disability Index at six weeks, three months, six months, and yearly up to four years.
Results: In the randomized cohort (304 patients enrolled), 66% of those randomized to receive surgery received it by
four years whereas 54% of those randomized to receive nonoperative care received surgery by four years. In the
observational cohort (303 patients enrolled), 97% of those who chose surgery received it whereas 33% of those who
chose nonoperative care eventually received surgery. The intent-to-treat analysis of the randomized cohort, which was
limited by nonadherence to the assigned treatment, showed no significant differences in treatment outcomes between
the operative and nonoperative groups at three or four years. An as-treated analysis combining the randomized and
observational cohorts that adjusted for potential confounders demonstrated that the clinically relevant advantages of
surgery that had been previously reported through two years were maintained at four years, with treatment effects of
15.3 (95% confidence interval, 11 to 19.7) for bodily pain, 18.9 (95% confidence interval, 14.8 to 23) for physical
function, and 214.3 (95% confidence interval, 217.5 to 211.1) for the Oswestry Disability Index. Early advantages (at
two years) of surgical treatment in terms of the secondary measures of bothersomeness of back and leg symptoms,
overall satisfaction with current symptoms, and self-rated progress were also maintained at four years.
continued
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Conclusions: Compared with patients who are treated nonoperatively, patients in whom degenerative spondylolisthesis and associated spinal stenosis are treated surgically maintain substantially greater pain relief and improvement
in function for four years.
Level of Evidence: Therapeutic Level II. See Instructions to Authors for a complete description of levels of evidence.

L

umbar decompression with fusion is commonly performed in the United States for patients with back
and leg symptoms due to spinal stenosis with or without degenerative spondylolisthesis1. There have been studies
comparing surgery with nonoperative treatment for spinal
stenosis, but they have included mixed groups of patients
with and without degenerative spondylolisthesis2-4. There
have been several studies comparing surgical techniques in
cohorts with degenerative spondylolisthesis, but they have
had small sample sizes and limited geographic participation
as well as a lack of nonoperative controls and validated outcome measures5-7.
The special methodological challenges of surgical trials
(e.g., compliance with treatment4-12) were addressed by the
design of the Spine Patient Outcomes Research Trial (SPORT),
in which a randomized cohort and a concurrent observational cohort were selected with the identical criteria and
evaluated with the same outcomes assessment8-10. In the
SPORT, as-treated comparisons with careful control for
potentially confounding baseline factors showed that patients
treated surgically for spinal stenosis and associated degenerative spondylolisthesis had substantially greater pain relief and
improvement in function during a two-year period than did
patients treated nonoperatively. In prior studies of spinal stenosis, the improvement observed early after surgery was reported to deteriorate and the advantage of surgery compared
with nonoperative treatment was found to have narrowed with
longer-term follow-up3-11. Therefore, in this study, we assessed
the stability of pain and functional outcomes out to four years
for patients with degenerative spondylolisthesis and associated
spinal stenosis.
Materials and Methods
Study Design
he SPORT was conducted at thirteen medical centers
with multidisciplinary spine practices in eleven states
in the United States. Institutional review board approval
was obtained at each center. The trial was registered with
ClinicalTrials.gov (NCT00000411). The SPORT included
both a randomized cohort and a concurrent observational
cohort of patients who declined randomization. This design improves the generalizability of the findings12. Additional background information is available in previous
publications 8-10,13,14 .

T

Patient Population
All patients had neurogenic claudication or radicular leg pain
with associated neurological signs, spinal stenosis seen on

cross-sectional imaging, degenerative spondylolisthesis seen
on standing lateral radiographs, symptoms that had persisted
for at least twelve weeks, and physician confirmation that
they were a surgical candidate. Patients with adjacent levels
of stenosis were eligible, but those with spondylolysis and
isthmic spondylolisthesis were not. Pre-enrollment nonoperative care was not specified but included physical therapy
(68%), epidural injections (55%), chiropractic care (25%),
anti-inflammatory medications (63%), and opioid analgesics
(30%). Enrollment began in March 2000 and ended in February 2005.
Study Interventions
The protocol surgery consisted of a standard posterior decompressive laminectomy with or without bilateral singlelevel fusion (autogenous iliac crest bone-grafting with or
without posterior pedicle screw instrumentation)8. The nonoperative protocol was ‘‘usual recommended care,’’ which
includes, at least, active physical therapy, education and
counseling with instructions regarding home exercise, and
nonsteroidal anti-inflammatory drugs if the patient can
tolerate them8,15.
Study Measures
The primary end points were the Short Form-36 (SF-36)
bodily pain and physical function scores16-19 and the American
Academy of Orthopaedic Surgeons MODEMS (Musculoskeletal Outcomes Data Evaluation and Management System)
version of the Oswestry Disability Index20 measured at six
weeks, three months, six months, and yearly up to four years.
If surgery was delayed for more than six weeks, additional
follow-up data were obtained at six weeks and three months
postoperatively. Secondary outcomes included patient selfreported improvement, satisfaction with current symptoms
and with care21, the Stenosis Bothersomeness Index2,22, the
Low Back Pain Bothersomeness Scale2, and the Leg Pain
Bothersomeness Scale2. The treatment effect was defined as the
difference in the mean changes, as compared with baseline,
between the surgical and nonoperative groups (the difference
in the difference).
SF-36 scores range from 0 to 100 points, with higher
scores indicating less severe symptoms; the Oswestry Disability
Index ranges from 0 to 100 points, with lower scores indicating
less severe symptoms; the Stenosis Bothersomeness Index
ranges from 0 to 24 points, with lower scores indicating less
severe symptoms; and the Low Back Pain and Leg Pain
Bothersomeness Scales range from 0 to 6 points, with lower
scores indicating less severe symptoms.
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Fig. 1

Exclusion, enrollment, randomization, and follow-up of trial participants. The values for surgery, withdrawal, and death
are cumulative over four years. For example, a total of three patients in the group assigned to receive surgery died during
the four-year follow-up period.
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Fig. 2

Intent-to-treat (ITT) compared with as-treated (AT) analysis for the SF-36 bodily pain and physical function scores
and the Oswestry Disability Index. RC = randomized cohort. Error bars indicate the 95% confidence intervals.

Statistical Methods
The statistical methods for the analysis of this trial have been
reported in previous publications9,10,13,14, and these descriptions
are repeated or paraphrased here as necessary. In the initial

analyses, the baseline characteristics were compared between
the patients in the randomized cohort and those in the observational cohort and between the surgical and nonoperative
groups in the combined cohort. The extent of missing data
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and the percentage of patients who had undergone surgery
were calculated for each study group at each scheduled followup point. Baseline predictors of the time until surgical treatment (including treatment crossovers) in both cohorts were
determined through a stepwise proportional-hazards regression model with a criterion of p < 0.1 to enter and p > 0.05 to
exit. Predictors of adherence to the assigned treatment and
missing follow-up visits at one, two, three, and four years were
determined through stepwise logistic regression. The primary
analyses consisted of comparisons of surgical and nonoperative treatments, on the basis of the changes from baseline at
each follow-up visit, with a mixed-effects model of longitudinal regression that included a random individual effect to
account for correlation between repeated measurements. The
randomized cohort was initially analyzed on an intent-to-treat
basis. Because of crossover, subsequent analyses were based on
treatments actually received.
In the as-treated analyses, the treatment indicator was a
time-varying covariate, allowing for variable times of surgery.
In the intent-to-treat analyses, all times were from enrollment.
In the as-treated analyses, the times were from the beginning of
treatment (that is, the time of surgery for the surgical group
and the time of enrollment for the nonoperative group).
Therefore, all changes from baseline before surgery were included in the estimates of the nonoperative treatment effect.
Changes after surgery were assigned to the surgical group, with
follow-up measured from the date of the surgery.
Repeated measures of outcomes were used as the dependent variables, and the treatment received was included as a timevarying covariate. Adjustments were made for postoperative visit
times with respect to the time of surgery in order to approximate
the designated follow-up times. Treatment comparisons were
performed at designated follow-up times. In addition, a global
significance test was based on the time-weighted average/area
under the curve analysis over all time periods23.
As-treated estimates of treatment effect from the randomized and observational cohorts were analyzed to establish
comparability. Subsequent analyses combined the two cohorts.
To adjust for potential confounding, baseline variables that
were associated with missing data or treatment received were
included as adjusting covariates in longitudinal regression
models. Computations were performed with the use of the
PROC MIXED procedure for continuous data and the PROC
GENMOD procedure for binary and non-normal secondary
outcomes from the SAS software package (version 9.1; SAS
Institute, Cary, North Carolina). Significance was defined as
p < 0.05 on the basis of a two-sided hypothesis test with no
adjustments made for multiple comparisons. The data for
these analyses were collected through May 1, 2008.
Source of Funding
Sources of funding included the National Institute of Arthritis
and Musculoskeletal and Skin Diseases (U01-AR45444) and
the Office of Research on Women’s Health, the National Institutes of Health, and the National Institute of Occupational
Safety and Health, the Centers for Disease Control and Pre-
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vention. The analyses and manuscript preparation were performed independently by the investigators.
Results
verall, 607 of 892 eligible participants were enrolled in the
degenerative spondylolisthesis SPORT trial; 304 were enrolled in the randomized cohort and 303, in the observational
cohort. In the randomized cohort, 159 patients were assigned
to receive surgery and 145, nonoperative treatment. Of the 159
assigned to receive surgery, 64% (101) underwent surgery by
two years and 66% (105), by four years. Of the 145 patients
assigned to receive nonoperative care, 49% (seventy-one) underwent surgery by two years and 54% (seventy-nine), by four
years (Fig. 1). In the observational cohort, 173 patients initially
chose surgery and 130 initially chose nonoperative care. Of the
173 who initially chose surgery, 97% (168) underwent surgery
by two years and had had no additional surgery by four years. Of
the 130 patients who initially chose nonoperative treatment,
25% (thirty-three) underwent surgery by two years and 33%
(forty-three) underwent surgery by four years. In both cohorts combined, 395 patients underwent surgery within four
years, with 87% (345) of them undergoing it within the first
year. At four years, 35% (212) of the 607 patients had had
only nonoperative treatment. A total of 601 patients (301
[99%] of the 304 enrollees in the randomized cohort and 300
[99%] of the 303 enrollees in the observational cohort), each
with at least one follow-up visit in the four-year period, were
included in the analysis (Fig. 1). The proportion of enrollees
who supplied data at each follow-up interval ranged from
70% to 92%, with losses due to dropouts, missed visits, and
deaths.

O

Patient Characteristics
A table in the Appendix shows the baseline characteristics and
clinical findings of participants in the randomized and observational cohorts. The cohorts were remarkably similar
except for their preferences for surgery (p < 0.001), with more
randomized patients unsure of their preference (39% [117] of
301 compared with 7% [twenty] of the 300 patients in the
observational cohort) and fewer randomized patients preferring either surgery (13% [thirty-eight of 301] compared with
43% [129 of 300]) or nonoperative treatment (15% [forty-four
of 301] compared with 28% [eighty-three of 300]).
The table in the Appendix also shows summary statistics
for the combined randomized and observational cohorts according to the treatment received. In the combined cohort, the
patients who underwent surgery within four years were, at
baseline, significantly younger and more likely to be receiving
compensation (for example, Workers’ Compensation or Social
Security benefits) than those who received nonoperative treatment. They also had significantly worse pain, function, disability, and symptoms than the patients in the nonoperative
group. The patients in the surgery group were significantly
more dissatisfied with their symptoms and more often rated
their symptoms as worsening at the time of enrollment; these
patients also definitely preferred surgery.
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TABLE I Change in Scores and Treatment Effects for Primary and Secondary Outcomes in the Randomized and Observational Cohorts
Combined, According to Treatment Received*
Mean
(Standard
Error) at
Baseline

ä

3 Yr
Op. Group†
(N = 326‡)

Nonop. Group†
(N = 162‡)

Treatment
Effect§

P Value

Primary outcomes#
SF-36 bodily pain score

32.6 (0.7)

32.4 (1.3)

15.5 (1.6)

SF-36 physical function score

33.7 (0.8)

25.1 (1.2)

9.1 (1.6)

Oswestry Disability Index

42.6 (0.6)

221.9 (0.96)

29.3 (1.2)

17.0 (13, 20.9)

<0.001

16.1 (12.3, 19.8)

<0.001

212.6 (215.5, 29.7)

<0.001

Secondary outcomes**
14.9 (0.2)

29.1 (0.35)

24.5 (0.46)

24.6 (25.8, 23.5)

<0.001

Leg Pain Bothersomeness Scale
Low Back Pain Bothersomeness Scale

4.6 (0.1)
4.2 (0.1)

23 (0.1)
22.1 (0.1)

21.6 (0.1)
21.4 (0.1)

21.3 (21.7, 21)
20.7 (21, 20.4)

<0.001
<0.001

Very or somewhat satisfied with symptoms (%)

4.2 (2)

66.1

36.2

29.9 (20.6, 39.3)

<0.001

87.8

69.3

18.5 (10, 27)

<0.001

71

25.2

45.8 (37.3, 54.3)

<0.001

Stenosis Bothersomeness Index

Very or somewhat satisfied with care (%)
Self-rated progress: major improvement (%)

*Scores are adjusted for age, sex, work status, body mass index, neuroforaminal involvement, depression, osteoporosis, joint problems, duration
of current symptoms, reflex deficit, number of moderately or severely stenotic levels, hypertension, treatment preference, other comorbidities
(including stroke; cancer; fibromyalgia; chronic fatigue syndrome; posttraumatic stress disorder; alcohol or drug dependency; lung, liver, kidney,
blood vessel, and nervous system disease; migraine; and anxiety), baseline SF-36 score, baseline Oswestry Disability Index, baseline Stenosis
Bothersomeness score, and center. †The values are given as the mean change from baseline (with the standard error in parentheses), except for
the values for satisfaction with symptoms and care and for self-rated progress, which are given as the percentages of patients at the time of followup. ‡The sample sizes for the as-treated analyses reflect the number of patients contributing to the estimate in a given time-period, with use of the
longitudinal modeling strategy explained in the Materials and Methods section, and may not correspond to the counts provided for each visit time
in Figure 1. §The treatment effect is the difference between the operative-group and nonoperative-group mean changes from baseline. The 95%
confidence interval is given in parentheses. #The SF-36 scores range from 0 to 100 points, with higher scores indicating less severe symptoms.
The Oswestry Disability Index ranges from 0 to 100 points, with lower scores indicating less severe symptoms.**The Stenosis Bothersomeness
Index ranges from 0 to 24 points, with lower scores indicating less severe symptoms, and the Leg Pain and Low Back Pain Bothersomeness
Scales range from 0 to 6 points, with lower scores indicating less severe symptoms.

These observations highlight the need to control for
baseline differences in the adjusted models. On the basis of the
selection procedure for variables associated with treatment,
missing data, and outcomes, the final as-treated models controlled for the following covariates: age, sex, work status, body
mass index, neuroforamen involvement, depression, osteoporosis, joint problems, duration of current symptoms, reflex deficit,
number of moderately or severely stenotic levels, hypertension,
treatment preference, other comorbidities (including stroke;
cancer; fibromyalgia; chronic fatigue syndrome; posttraumatic
stress disorder; alcohol or drug dependency; lung, liver, kidney,
blood vessel, and nervous system disease; migraine; and anxiety), baseline SF-36 score, baseline Oswestry Disability Index,
baseline Stenosis Bothersomeness score, and center.
Nonoperative Treatments
Nonoperative treatments used during the SPORT included
physical therapy (43% [176 of 412]), epidural steroid injections
(47% [192 of 412]), nonsteroidal anti-inflammatory drugs
(54% [224 of 412]), and opioids (35% [146 of 412]). Nonoperative treatments were similar in the randomized cohort and
the observational cohort, although more patients in the randomized cohort than in the observational cohort reported visits

to a surgeon (48% [122 of 252] compared with 38% [sixty of
160], p = 0.04), receiving injections (51% [128 of 252] compared
with 40% [sixty-four of 160], p = 0.04), and opioid use (40% [100
of 252] compared with 29% [forty-six of 160], p = 0.03).
Surgical Treatment and Complications
The median surgical time for the combined cohort was 198
minutes, with a mean blood loss of 583 mL (see Appendix). There
was no significant difference between the cohorts with regard to
the rates of intraoperative blood replacement, but there was a
difference in the postoperative transfusion rates (16% [twentynine of 178] in the randomized cohort compared with 24% [fiftyone of 209] in the observational cohort, p = 0.08). The most
common surgical complication was a dural tear (11% [forty-one
of 387]). The four-year reoperation rate was 15% (fifty-nine of
387), and the rate of recurrent stenosis was 5% (nineteen of 387).
Within four years after enrollment, there were seven
deaths in the nonoperative group, compared with twenty-two
deaths expected on the basis of age and sex-specific mortality
rates24, and seventeen deaths in the surgery group, compared
with twenty-eight expected. The hazard ratio based on a
proportional-hazards model adjusted for age was 1.9 (95% confidence interval, 0.76 to 4.6; p = 0.17). All twenty-four deaths
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TABLE I (continued)

4 Yr
Op. Group†
(N = 264‡)

Nonop. Group†
(N = 131‡)

Treatment
Effect§

P Value

Primary outcomes#
31.1 (1.4)

15.8 (1.8)

15.3 (11, 19.7)

<0.001

26.6 (1.3)

7.7 (1.7)

18.9 (14.8, 23)

<0.001

223 (1)

28.6 (1.3)

214.3 (217.5, 211.1)

<0.001

29.2 (0.38)
23 (0.1)

23.9 (0.5)
21.5 (0.2)

25.3 (26.5, 24.1)
21.5 (21.9, 21.1)

<0.001
<0.001

22.1 (0.1)

21.2 (0.1)

21.0 (21.3, 20.6)

<0.001

63.5

30.2

33.4 (23.4, 43.4)

<0.001

86.6

67.8

18.7 (9, 28.5)

<0.001

67.1

21

46.1 (37, 55.2)

<0.001

Secondary outcomes**

were independently reviewed, and eighteen were judged to be
not related to the treatment. Four deaths were of unknown
cause but occurred between 621 and 1379 days following the
surgery. Two deaths, both in the surgical group, were judged
to be potentially related to the treatment; one patient died of
respiratory distress thirty-two days after the surgery, and the
other died of sepsis eighty-two days after the surgery.
Crossover
Nonadherence to the treatment assignment affected both arms
of the SPORT: patients in the surgical arm chose to delay or
declined surgery, and patients in the nonoperative arm crossed
over to receive surgery (Fig. 1). The characteristics of crossover
patients that differed significantly from those of the patients
who did not cross over are shown in a table in the Appendix.
Patients who crossed over to receive nonoperative care were
older, had less pain and disability, were less bothered by their
symptoms, and had stronger baseline treatment preferences
for nonoperative care as compared with patients who did not
cross over. In the group randomized to receive surgery, improvements in pain and function scores at the early follow-up
intervals also predicted nonadherence with surgical treatment.
In the group randomized to receive nonoperative care, those
who crossed over to receive surgery were younger, more often
married, and more dissatisfied with their symptoms, and they
had a stronger baseline preference for surgery.
Main Treatment Effects
The intent-to-treat analysis of the randomized cohort showed
no significant differences between surgery and nonoperative
care on the basis of overall global hypothesis tests for differences in mean changes from baseline (Fig. 2). Estimated
treatment effects at four years slightly favored nonoperative
treatment but were not significant; these effects were 22 for
SF-36 bodily pain (95% confidence interval, 28.6 to 4.6, p =

0.56), 23.1 for physical function (95% confidence interval,
29.2 to 3, p = 0.32), and 4.1 for the Oswestry Disability Index
(95% confidence interval, 20.8 to 9.1, p = 0.1).
In the as-treated analysis, the treatment effects for the
randomized and observational cohorts were similar at four
years (Fig. 2). In the randomized and observational groups,
respectively, these effects were 17.1 (95% confidence interval,
10.9 to 23.4) and 13 (95% confidence interval, 6.6 to 19.4) for
bodily pain, 19.2 (95% confidence interval, 13.4 to 25.1) and
18.8 (95% confidence interval, 12.7 to 24.9) for physical
function, and 16.2 (95% confidence interval, 220.7 to 211.6)
and 212.2 (95% confidence interval, 216.8 to 27.5) for the
Oswestry Disability Index.
The global hypothesis test comparing the as-treated
treatment effects between the randomized and observational
groups over all time periods showed no difference between the
cohorts (p = 0.18 for bodily pain, p = 0.17 for physical function, and p = 0.77 for the Oswestry Disability Index).
Results from the intent-to-treat and as-treated analyses
of the two cohorts are compared in Figure 2. The as-treated
treatment effects significantly favored surgery in both cohorts.
In the combined analysis, the treatment effects were significantly in favor of surgery for all primary and secondary outcome measures at each time point out to four years (Table I).
Subgroup Analyses
Table II shows the results of subgroup analyses comparing the
time-weighted average outcomes between patients with and
those without neurogenic claudication on baseline clinical
examination and between patients with and those without a
neurological deficit on baseline clinical examination. Approximately 85% of the subjects had neurogenic claudication,
while the remaining 15% had more radicular symptoms with
evidence of nerve root irritation. Those with neurogenic
claudication had similar overall results of surgery, as compared
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TABLE II Time-Weighted Average of Treatment Effects at Four Years According to Whether the Patient Had Neurogenic Claudication
or Any Neurological Deficit
Mean Change in Score Compared with Baseline* (Standard Error)
Op. Group

Nonop. Group

Treatment Effect
(95% Confidence
Interval)

SF-36 bodily pain score
Neurogenic claudication

31.3 (0.9)

12.9 (1.1)

18.4 (16 to 20.8)

No neurogenic claudication

29.7 (2.2)

19.2 (2.4)

10.4 (5.2 to 15.7)

P value

0.51

0.015

0.006

SF-36 physical function score
Neurogenic claudication
No neurogenic claudication
P value

25.3 (0.9)
24.3 (2.2)
0.67

8.3 (1)
12.8 (2.4)

17 (14.7 to 19.3)
11.5 (6.5 to 16.6)

0.083

0.047

Oswestry Disability Index
Neurogenic claudication
No neurogenic claudication
P value

223 (0.7)

27.4 (0.8)

215.6 (217.4 to 213.8)

220.6 (1.7)

211.8 (1.9)

28.8 (212.8 to 24.9)

0.20

0.035

0.002

SF-36 bodily pain score
Any neurological deficit

31.8 (1.2)

13.7 (1.4)

18 (15.1 to 21)

No neurological deficit

30.1 (1.3)

14.3 (1.5)

15.8 (12.7 to 19)

P value

0.37

0.79

0.29

SF-36 physical function score
Any neurological deficit
No neurological deficit
P value

26.5 (1.2)
23.6 (1.3)
0.11

7.6 (1.3)
11 (1.5)
0.11

19 (16.2 to 21.8)
12.7 (9.7 to 15.7)
0.002

Oswestry Disability Index
Any neurological deficit

222.5 (0.9)

27.2 (1.1)

215.3 (217.5 to 213.1)

No neurological deficit

222.9 (1)

29.4 (1.2)

213.5 (215.9 to 211.2)

P value

0.78

0.20

0.27

*The SF-36 scores range from 0 to 100 points, with higher scores indicating less severe symptoms. The Oswestry Disability Index ranges from 0
to 100 points, with lower scores indicating less severe symptoms.

with those without neurogenic claudication, but showed less
improvement after nonoperative care; this resulted in a significantly greater surgical treatment effect in the neurogenic
claudication group. The presence of a neurological deficit did
not result in significant differences in either the surgical or the
nonoperative outcomes, and there was no consistent difference
in treatment effects.
Only 7% of the subjects had compensation claims, so
this subgroup was too small to allow meaningful comparisons.
Ancillary studies from the SPORT have provided information
on the effect of baseline radiographic predictors (spondylolisthesis grade, degree of mobility on flexion radiographs, and disc
space height) on outcomes25 as well as the relative outcomes of
surgery in subgroups based on the type of fusion performed26.
Discussion
ur intent-to-treat analysis of patients who had had, for at
least twelve weeks, signs and symptoms of degenerative
spondylolisthesis with spinal stenosis confirmed by radio-

O

graphic studies demonstrated that surgery had no significant
advantage over nonoperative treatment; at the three and fouryear follow-up points, nonoperative treatment showed a slight
but not a significant advantage. However, these results must be
viewed in the context of substantial rates of nonadherence to
the assigned treatment. This mixing of treatments generally
biases effect estimates toward the null9,10,13,14,27.
The treatment effect in favor of surgery that was found in the
as-treated analysis suggests that the intent-to-treat analysis underestimated the true effect of surgery. The effect was seen as early
as six weeks, was maximum by six to twelve months, and persisted
over four years. The nonoperative treatment group demonstrated
only modest improvement over time. The results in both treatment groups were maintained between two and four years.
This study provided an opportunity to compare the results between patients who were willing to participate in a
randomized study (the randomized cohort) and those who were
not (the observational cohort). These two cohorts were remarkably similar at baseline. Other than treatment preference,
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the only significant differences were small ones in the level and
location of the stenosis on baseline imaging. The cohorts also
had similar outcomes, with no significant differences between
the treatment effects in the as-treated analyses, findings that
support the validity of the combined analysis. Although these
analyses were not based entirely on randomized treatment assignments, the results were strengthened by the use of specific
inclusion and exclusion criteria, the large sample size, and the
adjustment for potentially confounding baseline factors28.
Comparisons with Other Studies
The characteristics of the participants and the short-term
outcomes in the SPORT as previously reported9 are similar to
those in studies of degenerative spondylolisthesis and of mixed
cohorts of patients who had stenosis with and without degenerative spondylolisthesis.
The surgical outcomes in the SPORT were generally
similar to those in previous surgical series. Herkowitz and
Kurz7 reported absolute improvements of 33% in scores for
back pain and 55% in scores for leg pain (on 6-point scales) at
an average of three years, results that are similar to the improvements of 30% and 43% (on 7-point scales), respectively,
seen in the SPORT at four years. Also, the improvements at
four years after surgery for degenerative spondylolisthesis in
the SPORT were similar to the outcomes of surgery in the
Maine Lumbar Spine Study (MLSS)2 of a mixed cohort of
patients who had stenosis with and without degenerative
spondylolisthesis. The improvements in the scores for the
bothersomeness of stenosis, leg pain, and low-back pain were
nearly identical in the two studies: 29.2, 23, and 22.1 points
in the SPORT and 29.4, 23.5, and 21.7 points in the MLSS.
Carragee et al. reported on the outcomes of fusion with
or without decompression in patients with isthmic spondylolisthesis29-31. They found improved outcomes with fusion
independent of decompression, particularly among those with
instability on flexion-extension radiographs. They also found
that circumferential fusion had some early advantage over
posterior fusion with instrumentation. However, isthmic
spondylolisthesis and degenerative spondylolisthesis, the focus of our study, are quite different disease processes; in
particular, decompression was important in our population
because all patients had neurogenic claudication or radicular
leg pain. In addition, Pearson et al. found that patients with
degenerative spondylolisthesis who had had more mobility
at baseline actually had better nonoperative outcomes than
those with less movement as documented radiographically 25,
the opposite of what was found in patients with isthmic
spondylolisthesis.
There was little evidence of harm from either treatment
in our study. In the interval between two and four years, there
were no cases of paralysis in either the surgical or the nonoperative group. The four-year rate of reoperation for recurrent stenosis or spondylolisthesis was 5%, and the overall
reoperation rate increased from 12% at two years to 15% at
four years (compared with 6.2% at four years in the MLSS2).
The perioperative mortality rate remained unchanged at 0.5%,
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which is less than the 1.3% rate seen in Medicare patients after
fusion surgery for spondylolisthesis24.
The four-year mortality rate was similar in the two
treatment groups and was lower than actuarial projections. The
rate in the nonoperative group was somewhat lower than that in
the operative group, although not significantly so. It should be
noted that higher rates of complications have been reported
with increasing age and coexisting medical conditions32.
Limitations
A major limitation of this study is the marked degree of nonadherence to the randomized treatment. This reduced the power
of the intent-to-treat analysis to demonstrate a treatment effect.
Although the as-treated analysis lacked the strong protection
from confounding conferred by randomization, these analyses
were carefully controlled for important covariates and yielded
results similar to those of prior studies2,7,9. Another limitation is
the heterogeneity of the treatment interventions. The choice of
nonoperative therapies as well as the decision regarding whether
and how to perform the fusions were at the discretion of the
treating physician and the patient. This resulted in a clinically
relevant comparison of the effectiveness of current treatment
practices but does not allow us to draw direct conclusions
regarding the efficacy of one specific surgical technique compared with one specific nonoperative treatment.
Overview
In the as-treated analysis, combining the randomized and
observational cohorts of patients with spinal stenosis secondary to degenerative spondylolisthesis, those treated surgically
were found to have significantly greater improvement in scores
for pain, function, satisfaction, and self-rated progress over
four years compared with patients treated nonoperatively. The
results in both groups were stable between two and four years.
Appendix
Tables showing baseline characteristics of the study cohorts, the types of operative treatments and complications, and predictions of adherence to treatment among
patients in the randomized cohort are available with the
electronic versions of this article, on our web site at jbjs.org (go
to the article citation and click on ‘‘Supplementary Material’’)
and on our quarterly CD/DVD (call our subscription department, at 781-449-9780, to order the CD or DVD). n
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